1 document found, page 1 of 1

Sort by Issue Date

Efeito da empagliflozina para além do controlo glicémico

Monteiro, Pedro; Aguiar, Carlos; Matos, Pedro; Silva‐Nunes, José; Birne, Rita; Branco, Patrícia; Calado, Joaquim; Melo, Miguel; Polónia, Jorge

The prevalence of type 2 diabetes (T2D) continues to increase, and its association with cardiovascular (CV) disease has led to the inclusion of CV endpoints in clinical trials on the treatment of T2D. This article explores the various trials already performed and under development in this field, with particular focus on the EMPA‐REG OUTCOME trial. In this trial, empagliflozin, a sodium‐glucose co‐transporter 2 ...


1 Results

Queried text

Refine Results

Author










Date


Document Type


Access rights


Resource


Subject